Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

Zero-order input occurs when a drug is administered through constant intravenous infusion and eliminated by nonlinear pharmacokinetics. This means the drug enters the bloodstream at a constant rate regardless of plasma concentration. The rate of change in plasma drug concentration follows specific mathematical equations that describe this linear input with nonlinear elimination kinetics.

First-order absorption occurs when oral drugs are absorbed and eliminated through nonlinear pharmacokinetics. Unlike zero-order input from constant IV infusion, first-order absorption means the drug absorption rate depends on the plasma concentration. The absorption follows concentration-dependent kinetics described by differential equations that account for this variable absorption rate.

Subcutaneously administered drugs follow a two-compartment model with two distinct elimination processes. The drug absorbs from the hypodermis into the blood and undergoes saturable receptor-mediated elimination in the bone marrow alongside nonsaturable elimination through the kidneys. Each elimination process is described by respective Michaelis-Menten parameters in differential equations.

Saturable elimination is a receptor-mediated process that becomes limited when drug concentration exceeds enzyme capacity, occurring in the bone marrow. Nonsaturable elimination through the kidneys continues linearly regardless of drug concentration. Together, these two processes in the two-compartment model create complex nonlinear pharmacokinetic behavior.

In nonlinear pharmacokinetics, drug clearance is dose-dependent and cannot be considered constant. Clearance may be divided into two parts, with α representing a dimensionless function of dose that ranges from 0 to 1. This dose-dependent clearance fundamentally distinguishes nonlinear from linear pharmacokinetic models and affects drug elimination half-life.

Understanding nonlinear drug elimination across different administration routes is essential for optimizing drug dosing regimens and ensuring therapeutic efficacy. Nonlinear elimination results in complex pharmacokinetic behaviors where drug concentration changes unpredictably with dose, potentially leading to adverse effects if dosing is not carefully adjusted based on individual pharmacokinetic parameters.

Differential equations describe the rate of change in plasma drug concentration for different administration routes and elimination pathways. For two-compartment models with multiple elimination processes, separate differential equations are defined for each compartment and elimination route, each incorporating respective Michaelis-Menten parameters to account for saturable and nonsaturable processes.